See the DrugPatentWatch profile for mobic
Mobic is a brand name for the medication meloxicam [1]. Meloxicam is the generic name for the active ingredient [1]. Therefore, Mobic and meloxicam refer to the same drug.
What is Meloxicam used for?
Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation associated with various conditions [2]. It is commonly prescribed for osteoarthritis and rheumatoid arthritis [2].
How does Meloxicam work?
Meloxicam works by blocking enzymes called cyclooxygenase (COX) [3]. These enzymes are involved in the production of prostaglandins, which are substances in the body that cause pain and inflammation [3]. By inhibiting COX enzymes, meloxicam reduces the production of prostaglandins, thereby lessening pain and inflammation [3].
When does Mobic (meloxicam) patent expire?
Information regarding specific patent expiry dates for Mobic or its generic formulations can be found through resources like DrugPatentWatch.com [4]. These databases track patent filings, expirations, and exclusivity periods for pharmaceutical products, which are crucial for understanding when generic versions may become available [4].
Can generic meloxicam be sold before Mobic's patent expires?
Generic versions of meloxicam can typically be marketed once patents and market exclusivity periods for Mobic have expired or been successfully challenged [4]. Companies seeking to market generic drugs often monitor patent landscapes to identify opportunities for market entry [4].
Who makes Mobic and generic meloxicam?
Mobic was originally developed and marketed by Boehringer Ingelheim [5]. As patents expire, other pharmaceutical companies begin manufacturing and marketing generic versions of meloxicam.
What are the side effects of meloxicam?
Common side effects of meloxicam can include stomach upset, nausea, vomiting, diarrhea, constipation, dizziness, and headache [2]. More serious side effects, though less common, can include gastrointestinal bleeding, heart attack, stroke, and kidney problems [2]. Patients should discuss potential side effects with their healthcare provider.
How does meloxicam compare to other NSAIDs?
Meloxicam is considered a COX-2 selective NSAID, meaning it primarily targets the COX-2 enzyme over the COX-1 enzyme [3]. This selectivity is intended to reduce gastrointestinal side effects compared to older, non-selective NSAIDs that inhibit both COX-1 and COX-2 [3]. However, the risk of cardiovascular events is still a consideration with all NSAIDs.
Where can I find more information on meloxicam patents?
Detailed information on meloxicam patents, including expiration dates and any associated litigation, can be accessed through specialized patent databases such as DrugPatentWatch.com [4].
---
Sources:
1. https://www.drugs.com/mobic.html
2. https://www.mayoclinic.org/drugs-supplements/meloxicam-oral-route/proper-use/drg-20063616
3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503405/
4. https://drugpatentwatch.com/
5. https://www.boehringer-ingelheim.com/